CVS HEALTH CORPORATION (CVS) — Analysis Summary
CVS HEALTH CORPORATION (CVS) has a market cap of $118.97B with year-over-year revenue growth of +7.8%. Net margin stands at 0.4%. The stock trades at a P/E ratio of 24.3.
Key Takeaways
- Revenue changed +7.8% year-over-year
- Net margin of 0.4%
- P/E ratio of 24.3
Compared to other companies in the RETAIL-DRUG STORES AND PROPRIETARY STORES sector, CVS posted revenue growth of +7.8% and trades at a P/E of 24.3.
CVS HEALTH CORPORATION (CVS)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Debt/EBITDA at 4.6x — elevated leverage
Interest coverage at 2.7x — limited headroom for earnings decline
Current ratio at 0.87x — current liabilities exceed current assets
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Sector
RETAIL-DRUG STORES AND PROPRIETARY STORES
Employees
300,000
Headquarters
WOONSOCKET, RI
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$2.66
Dividend Yield
2.86%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.